Nrf2 activators and modulators have been shown to attenuate atherosclerosis, I/R injury, hypertension, and cardiac hypertrophy in animal models and may have therapeutic potential for human cardiovascular diseases [227,228]. The gene discussed is NFE2L2; the disease is cardiovascular disorder.